EUVIMEDEUVIMED entdecken
Crossref

A Mesoporous Magnetic Fe 3 O 4 /BioMOF-13 with a Core/Shell Nanostructure for Targeted Delivery of Doxorubicin to Breast Cancer Cells

Reza Taheri-Ledari iD, Simindokht Zarei-Shokat, Fateme Sadat Qazi, Mostafa Ghafori-Gorab, Fatemeh Ganjali iD, Amir Kashtiaray, Mohammad Mahdavi, Maliheh Safavi, Ali Maleki iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.3c14363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Reza Taheri-Ledari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Doxorubicin, Drug Carriers, Drug Delivery Systems. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Iran University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDoxorubicinDrug CarriersDrug Delivery SystemsMagnetite NanoparticlesMetal-Organic FrameworksFemaleHumansCell Line, TumorCell SurvivalDrug LiberationPorosity

Stichwörter der Autor:innen

Bio-MOF-13breast cancercore/shell nanostructuredoxorubicintargeted drug delivery

Substanzen

DoxorubicinDrug CarriersMagnetite NanoparticlesMetal-Organic Frameworks

Autor:innen und Institutionen

  • Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.
  • Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran 14166-34793, Iran.
  • Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), P.O. Box 3353-5111, Tehran 33531-36846,, Iran.

ORCID-Profile: Reza Taheri-Ledari, Fatemeh Ganjali, Ali Maleki

Förderung

  • Iran University of Science and Technology

Zitieren

APA

Taheri-Ledari, R., Zarei-Shokat, S., Qazi, F. S., Ghafori-Gorab, M., Ganjali, F., Kashtiaray, A., Mahdavi, M., Safavi, M., & Maleki, A. (2025). A Mesoporous Magnetic Fe 3 O 4 /BioMOF-13 with a Core/Shell Nanostructure for Targeted Delivery of Doxorubicin to Breast Cancer Cells. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c14363

Vancouver

Taheri-Ledari R, Zarei-Shokat S, Qazi FS, Ghafori-Gorab M, Ganjali F, Kashtiaray A, et al. A Mesoporous Magnetic Fe 3 O 4 /BioMOF-13 with a Core/Shell Nanostructure for Targeted Delivery of Doxorubicin to Breast Cancer Cells. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.3c14363

BibTeX
@article{TaheriLedari2025,
  author = {Taheri-Ledari, Reza and Zarei-Shokat, Simindokht and Qazi, Fateme Sadat and Ghafori-Gorab, Mostafa and Ganjali, Fatemeh and Kashtiaray, Amir and Mahdavi, Mohammad and Safavi, Maliheh and Maleki, Ali},
  title = {A Mesoporous Magnetic Fe 3 O 4 /BioMOF-13 with a Core/Shell Nanostructure for Targeted Delivery of Doxorubicin to Breast Cancer Cells},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.3c14363}
}
Kostenlos starten →